Skip to main content

Day: January 8, 2022

Core One Labs Now Also Working to Biosynthesize DMT and Receives License

Written by Customer Service on . Posted in Public Companies.

VANCOUVER, British Columbia, Jan. 08, 2022 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce that it has progressed its work on biosynthesizing N,N-Dimethyltryptamine (“DMT”) and has been approved by Health Canada to add N,N-Dimethyltryptamine (“DMT”) to the schedule of approved controlled substances under the existing licence granted by the Controlled Drugs and Substances Act (”CDSA”) Dealer’s Licence (the “Licence”) which allows its wholly owned subsidiary Vocan Biotechnologies Inc. (“Vocan”) to research and produce biosynthetic psilocybin. Furnished with its renewed licence in the second half of 2021, and having now received approval to add DMT to its licence coverage, the Company’s wholly-owned subsidiary Vocan Biotechnologies...

Continue reading

COVAXIN™ (BBV152) Booster Dose Study Demonstrates Robust Immune Responses and Long-Term Safety

Written by Customer Service on . Posted in Public Companies.

Participants receiving a booster dose six months after second dose of COVAXIN™ saw significant increase (>10-fold across Alpha, Beta, Delta and Delta Plus variants) in neutralizing titers compared to baseline at six months Persistence of memory B and T cell immune responses at six months post second dose Pronounced SARS-CoV-2-specific T cell response to COVAXIN™ before and after the booster dose may confer durable and long-term protective efficacy No serious adverse events such as hospitalizations or deaths were reported Effectiveness of COVAXIN™ against the Omicron strain is currently being studied and will be reported shortlyMALVERN, Pa., Jan. 08, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics and vaccines, announced...

Continue reading

Clear Blue Technologies Provides Update to Convertible Debenture Financing and Engages Firm to Drive Social Media Engagement

Written by Customer Service on . Posted in Public Companies.

TORONTO, Jan. 07, 2022 (GLOBE NEWSWIRE) — Clear Blue Technologies International Inc. (“Clear Blue”) (TSXV: CBLU), the Smart Off-Grid™ Company, today announces an adjustment to the previously announced issuance of convertible unsecured subordinated debentures in 2021. The Company completed a private placement offering of convertible unsecured subordinated debentures (the “Debentures”) for gross proceeds of C$2,799,000. With the second tranche completed, and cumulative gross proceeds of C$4,334,000 (the “Offering”), the Company still exceeded the cumulative funding target of C$4 million, previously announced on October 29, 2021. As a result of this change, corrections in the previously announced finders’ fees and broker warrants, for introducing certain subscribers to the Offering, are as follows. The Company paid finders’ fees in...

Continue reading

CVB Financial Corp. Announce Completion of the Merger with Suncrest Bank

Written by Customer Service on . Posted in Mergers And Acquisitions.

ONTARIO, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) — CVB Financial Corp. (the “Company”) announced today that the planned merger between CVBF’s wholly-owned banking subsidiary, Citizens Business Bank (“Citizens”), and Suncrest Bank (“Suncrest”) has been completed, effective at 6:00 p.m. (Pacific Standard Time) on January 7, 2022. Suncrest was merged with and into Citizens, in accordance with the terms and conditions of that certain Agreement and Plan of Reorganization and Merger (“Merger Agreement”), dated as of July 27, 2021, by and among the Company, Citizens and Suncrest, in a stock and cash transaction valued at approximately $237 million in aggregate, or $18.63 per Suncrest share based on CVB Financial Corp.’s closing stock price of $22.87 on January 7, 2022. Under the terms of the Merger Agreement, the Company issued approximately...

Continue reading

Corvus Gold Announces Intention to Delist from NASDAQ Capital Market

Written by Customer Service on . Posted in Public Companies.

VANCOUVER, British Columbia, Jan. 07, 2022 (GLOBE NEWSWIRE) — Corvus Gold Inc. (“Corvus” or the “Company”) – (TSX: KOR, NASDAQ: KOR) announces that it has notified the NASDAQ of its intention to voluntarily delist all of its securities from the Nasdaq Capital Market (“NASDAQ”), assuming satisfaction of the closing conditions of the previously announced plan of arrangement (the “Arrangement”) between Corvus, 1323606 B.C. Unlimited Liability Company, and AngloGold Ashanti Holdings plc., including the approval of the Arrangement by, and the obtainment of the final order from, the Supreme Court of British Columbia, and the successful completion of the transaction. Following the completion of the Arrangement, the Company will become a wholly-owned indirect subsidiary of AngloGold Ashanti Limited. The Company has submitted a notice...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.